Recruiting Ankylosing Spondylitis Studies in Caba
A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.
This study is to investigate the ability of LXE408 to reduce or remove the level of parasites in the blood of people with chronic Chagas disease. Participants must have chronic Chagas disease without ...
Iptacopan in Patients With ANCA Associated Vasculitis
The purpose of this study is to evaluate the efficacy and safety of iptacopan compared to standard of care (SOC) to induce and maintain remission in study participants with active granulomatosis with ...
About Ankylosing Spondylitis Clinical Trials in Caba
Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.
There are currently 2 ankylosing spondylitis clinical trials recruiting participants in Caba, BUENOS%20AIRES. These studies are seeking a combined 208 participants. Research is being sponsored by Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ankylosing Spondylitis Clinical Trials in Caba — FAQ
Are there ankylosing spondylitis clinical trials in Caba?
Yes, there are 2 ankylosing spondylitis clinical trials currently recruiting in Caba, BUENOS%20AIRES. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Caba?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Caba research site will contact you about next steps.
Are clinical trials in Caba free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Caba studies also compensate for your time and travel.
What ankylosing spondylitis treatments are being tested?
The 2 active trials in Caba are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.
Data updated March 2, 2026 from ClinicalTrials.gov